From: A proposed prognostic 7-day survival formula for patients with terminal cancer
Training (n = 374)
Validation* (n = 349)
Sensitivity
80.9%
71.0%
Specificity
65.9%
57.7%
PPV
42.6%
26.8%
NPV
91.7%
90.1%